TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

31.10$ +0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement COAG
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – 0.00 0.00
– – – 0.00
– – – 0.00
– – 0.44 0.68
– – 0.09 0.19
– – 0.53 0.87
– – -0.53 -0.87
– – -0.51 -0.80
– – 0.00 0.00
– – -0.51 -0.80
– – -0.53 -0.86

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?